Sensitivity, Specificity, and Predicted Value
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Predicting Molecular Geometry
Prediction Intervals
Insulin Secretory Vesicles
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 9, 2026

Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells
Published on: February 2, 2024
Lakmini Pinnaduwage1, Chang Ye1, Anthony J Hanley1,2,3
1Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada.
Changes in liver enzymes (ALT/AST ratio) and fetuin-A over time predict future insulin resistance and beta-cell dysfunction in women with prior gestational dysglycemia, indicating diabetic risk.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: